Top Stories

Instant Spin

BAC Pays Its Dues; Freight Cars Don't Lie: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about Bank of America's settlement and using trains as an indicator.

Walgreen Trails CVS in the In-Store Clinic Race to Keep You Healthy

CVS dominates with its 'MinuteClinics,' leaving Walgreen in its dust as both face increasing competition from Wal-Mart and Target.

Tracking the Bank Settlements: A Nonprofit Backed by Banks

Enterprise Community Partners' report calls a $13 billion JPMorgan settlement 'reasonable' for consumers, but the report doesn't disclose that Enterprise receives substantial backing from the bank.

Why Valero Energy Is a Stock Worth Remembering

Valero Energy could bounce back with higher volume from the Gulf of Mexico and strength in ethanol segment.

Sprint Answers Competition With Lowest 'Unlimited' Rates

Sprint cuts $20 from the price of its monthly unlimited data plan but changes some of the rules.

Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf

Emerging market pharmaceutical sales are exploding. Find out if Abbott Laboratories or Johnson & Johnson is best positioned to take advantage of the booming emerging market pharmaceutical market.

Biotech Stock Mailbag: Threshold, Galena, CytRx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Market Data

Dow Jones Industrial Average ^DJI 17,001.2200
S&P 500 Index ^GSPC 1,988.4000
NYSE Composite Index ^NYA 10,947.3300
NASDAQ Composite ^IXIC 4,538.5510
See All Market Data...
Section News



Winners and Losers


The Economy




Apps We Like